-+ 0.00%
-+ 0.00%
-+ 0.00%
ConvaTec raises 2026 organic revenue growth forecast excluding InnovaMatrix to 6.25%-7%
Share
Listen to the news
ConvaTec raises 2026 organic revenue growth forecast excluding InnovaMatrix to 6.25%-7%
  • ConvaTec raised 2026 organic revenue growth guidance, excluding InnovaMatrix, to 6.25%-7% from 5.5%-6.5%.
  • Ten-month organic revenue growth reached 6.6%, excluding InnovaMatrix, led by Infusion Care and Continence Care.
  • Full-year Infusion Care growth is now forecast at double digits, up from high single digits, supported by order phasing and improved manufacturing.
  • Adjusted operating margin guidance remains at least 23%, versus 22.3% in 2025, with another year of double-digit EPS growth expected.
  • Medium-term targets remain 6%-8% organic revenue growth and a mid-20s operating margin from 2027, despite expected inflation of 3%-4% next year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ConvaTec Group plc published the original content used to generate this news brief on November 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending